| News |
![]()
|
MERIDIO CLOSES $8.4 ... | | | INDEPENDENT RESEARCH... | | | ZANTAZ® NAMES STEVEN... |
![]()
|
![]() |
![]() |
![]() |
INDEPENDENT RESEARCH FIRM CITES AUTONOMY AND ISABEL HEALTHCARE FOR "SHARPEN[ING] DOCTORS' DIAGNOSES"
Together Autonomy and Isabel Healthcare bring life saving information to physicians' fingertips
Cambridge, England - November 2, 2004 - Autonomy Corporation plc (Nasdaq: AUTN; LSE: AU.) a global leader in infrastructure software for the enterprise, today announced that Isabel Healthcare, a ground breaking and award-winning clinical decision support system has been cited by independent industry analysts, Forrester Research for its ability to support the diagnostic process. The full report, entitled Search Sharpens Doctors' Diagnoses is available at www.forrester.com.
In the September 2004 report, Laura Ramos, Vice President, Forrester Research cites Isabel Healthcare and their use of innovative technology from Autonomy which encourages physicians to consider all the diagnostic possibilities and really understand the more severe implications certain common symptoms could signal: "Isabel ... is a hosted service that prompts physicians to consider different diagnoses using a Web-based, point and click interface. Isabel displays checklists of likely diagnoses grouped by systemic or clinical specialty that help reduce the consequences of clinical ignorance and omission." The report goes on to cite Isabel's ability, using world renowned technology from Autonomy to "put the clinician at the center" and "supply alternatives in the context of clinical workflow". Ramos validates both Isabel and Autonomy's vital contribution to pediatric medicine concluding "the capabilities Isabel provides fill an important need in pediatric emergency medicine."
Calling the partnership between Autonomy and healthcare a "good match", Ramos acknowledges the pivotal role played by Autonomy's unique IDOL technology which enables clinicians to relate ideas conceptually: "Autonomy powers Isabel's diagnosis suggestions and increases the likelihood that the system will produce relevant alternative diagnoses, not just keyword matches. Autonomy's software helps Isabel find the best matches between symptoms and diseases, not necessarily the only ones. Isabel highlights the unique benefits that Autonomy delivers to the healthcare industry".
"This report celebrates the success and vision of the Isabel project, which, using Autonomy's IDOL technology, has delivered invaluable advice and information to more than 20,000 physicians around the globe" said Charlotte Herbert, Marketing Manager, Autonomy. "We are incredibly proud to be providing the core technology behind such an important application."
Dr Joseph Britto, Clinical Director of Isabel Healthcare said, "This research from Forrester confirms Isabel's importance in pediatric medicine and gives us great satisfaction that our efforts to develop technology that has a positive impact on delivery of healthcare to children is being recognized by both the medical profession and by leading industry analysts. There is an overwhelming demand for Isabel and we're looking forward to more physicians around the world being able to get access to diagnostic alternatives that continue to save lives."
About Autonomy
Autonomy Corporation plc (Nasdaq: AUTN; LSE: AU.) is a global leader in infrastructure software for the enterprise. Autonomy's technology powers applications dependent upon unstructured information including call center, customer relationship management, knowledge management, enterprise portals, enterprise resource planning, online publishing and security applications. Autonomy's customer base includes more than 1,000 global companies including BAE Systems, Ford, Ericsson, Royal Sun Alliance, Sun Microsystems and public sector agencies including the U.S. Department of Defense, NASA and the U.S. Department of Energy. Strategic reseller and OEM partners include leading companies such as ATG, BEA, Business Objects, Citrix, Computer Associates, EDS, IBM Global Services, Novell, Novient, Veritas, Vignette, Supportsoft and Sybase. The company has offices worldwide.
The Autonomy Group of companies includes: Aungate, a leading supplier of electronic communications management technology for regulatory compliance in the enterprise; Audentify, a leading supplier of next-generation contact center technology; and Virage, a leading provider of rich media communication and content management software.
About Isabel Healthcare Ltd
Isabel Healthcare is a global leader in Diagnosis Reminder systems for physicians. Isabel is an award-winning, clinical decision support system. Its unique feature is a diagnosis reminder system, which instantly gives the physician a checklist of likely diagnoses. Using the same proprietary technology, which powers the diagnosis reminder tool, it also mobilises knowledge to help the physician find relevant and specific answers to their clinical questions more easily and quickly. Isabel integrates knowledge from respected medical textbooks, annotated images, journal abstracts categorized into, ‘What's New' and ‘Lessons Learnt from Error' and Algorithms all linked together through comprehensive diagnosis taxonomy. Isabel has undergone a robust, peer-reviewed validation process to demonstrate its accuracy and efficacy.
Isabel Healthcare's customer base includes hospitals in the UK and USA and it has offices in London and Houston.
For more information on Isabel Healthcare Ltd, or to speak with a member of the Isabel Team team, please contact Blaise Hammond / Dan Alder on Tel: 020 8956 2709 or email blaise@fusepr.com/dan@fusepr.com.
Caution Concerning Forward-Looking Statements
With the exception of historical information, the matters set forth in this news release are forward-looking statements that involve risks and uncertainties. A number of important factors could cause actual results to differ materially from those in the forward-looking statements. These factors include, among others, technology risks, including dependence on core technology; fluctuations in quarterly results; dependence on new product development; rapid technological and market change; reliance on sales by others; management of growth; dependence on key personnel; rapid expansion; growth of the Internet; financial risk management; and future growth subject to risks. These factors and other factors, which could cause actual results to differ materially are also discussed in the company's filings with the United States Securities and Exchange Commission, including Autonomy's Annual Report on Form 20-F and Registration Statements on Form F-1.
| For more information, please contact: | |
|
Beth Ladd Autonomy Corporation plc +1 415/243-9955 bethl@us.autonomy.com |
Charlotte Herbert Autonomy Corporation plc +44 (0) 1223 448 000 charlotteh@autonomy.com |
|
Albert Fong Schwartz Communications, Inc. +1 415/512-0770 autonomy@schwartz-pr.com |
Edward Bridges Financial Dynamics +44 (0) 207 831 3113 edward.bridges@fd.com |
Forthcoming Events
Archived Events
| Promote Webinar |
| Power Webinar |
This is a selection of our forthcoming events, please visit our seminars page for more information.
Automatic Hyperlinks provided by IDOL Server
|
|
|
|
|
|
|
|
|
|
|
This is a small selection of the Autonomy case studies available, please visit our publications site at http://publications.autonomy.com/ for more information.
Automatic Hyperlinks provided by IDOL Server























































Find us on Facebook
Follow us on Twitter
See us on YouTube
Find us on LinkedIn







